¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦75Â÷ ´ëÇѺñ´¢ÀÇÇÐȸ Á¤±âÇмú´ëȸ (DAY1) : 2023-11-01

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

Á¦75Â÷ ´ëÇѺñ´¢ÀÇÇÐȸ Á¤±âÇмú´ëȸ (DAY1) : 2023-11-01
±³À°ÀÏÀÚ : 2023-11-01
±³À°Àå¼Ò : ¼­¿ï COEX ºÏ¹® 103 ¿Ü

±³À°ÁÖÁ¦ : Á¦75Â÷ ´ëÇѺñ´¢ÀÇÇÐȸ Á¤±âÇмú´ëȸ (DAY1)

ÁÖÃÖ±â°ü : ´ëÇѺñ´¢ÀÇÇÐȸ(19.2 ¸íĪº¯°æ ´ëÇѺñ´¢±â°úÇÐȸ)
´ã´çÀÚ : À̼¼Èñ
¿¬¶ôó : 02-573-8190  

À̸ÞÀÏ : urology@urology.or.kr

±³À°Á¾·ù : ºñ´¢ÀÇÇаú

Âü¼®¿¹»óÀÎ : 900¸í
Èñ¸ÁÆòÁ¡ : 6Á¡ (ÀÏ¹Ý 4Á¡ / Çʼö 2Á¡)

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 56ºÐ

¼¼ºÎ¼ö°­·á : 150,000¿ø  

ºñ°í " # »çÀüµî·Ï ±âÁØ ¨çºÀÁ÷,°³¿øȸ¿ø:150,000¿ø ¨è±ºÀÇ°ü,°øº¸ÀÇ:80,000¿ø ¨éÀü°øÀÇ:80,000¿ø ¨êŸ°úÀü¹®ÀÇ:250,000¿ø"


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 11¿ù 01ÀÏ 201È£ 09:00~09:40 What is preceptor role for urologist¡¯s ¾çÀº¹è(¿¬¼¼ÀÇ´ë ÀÇÇб³À°°ú)

±³À°½Ã°£ 11¿ù 01ÀÏ 201È£ 09:40~10:00 How to educate residents training in clinic ÇÏÁö¿ë(°è¸íÀÇ´ë)

±³À°½Ã°£ 11¿ù 01ÀÏ 202+203È£ 10:00~10:30 ¼ö¼ú½Ç CCTV ¼³Ä¡ ¹ýÁ¦È­¿¡ µû¸¥ ºñ´¢ÀÇÇаúÀÇ ´ëÃ¥ ¼ÛÇÊÇö(¿µ³²ÀÇ´ë) Çʼö

±³À°½Ã°£ 11¿ù 01ÀÏ 202+203È£ 10:30~11:00 ºñ´ë¸é Áø·á½Ã¹ü»ç¾÷¿¡ ´ëÇÑ ÀÇ·á¹ý Ãø¸é¿¡¼­ÀÇ ºñ´¢ÀÇÇаú ´ëÃ¥ ±è¿¬ÁÖ(´ë±¸ÆÄƼ¸¶º´¿ø) Çʼö

±³À°½Ã°£ 11¿ù 01ÀÏ 202+203È£ 11:00~11:30 ºñ´¢ÀÇÇаú ¿µ¿ª¿¡¼­ ÃÊ°í°¡ ºñ±Þ¿© ¼ú±â¿¡ ´ëÇÑ ±× ¹üÀ§¿Í À±¸®Àû ÀÚ¼¼ °¨¼ºÃ¶(°æ»óÀÇ´ë) Çʼö

±³À°½Ã°£ 11¿ù 01ÀÏ 202+203È£ 11:30~12:00 ºñ´¢ÀÇÇаú Àǻ簡 ¹Ù¶óº» °£È£»ç ÁعýÅõÀï ÃÖżö(°æÈñÀÇ´ë) Çʼö

½Ä»ç 11¿ù 01ÀÏ 12:00~13:00 ½Ä»ç ()

±âŸ 11¿ù 01ÀÏ 103È£ 13:00~13:04 clincally complete response in patient with MIBC after neoadjuvant chemotherapy: what is next? - Case presentation ³ëÅÂÀÏ(°í·ÁÀÇ´ë)

±³À°½Ã°£ 11¿ù 01ÀÏ 103È£ 13:04~13:17 clincally complete response in patient with MIBC after neoadjuvant chemotherapy: what is next?  - Dadical cystectomy ¼­È£°æ(±¹¸³¾Ï¼¾ÅÍ)

±³À°½Ã°£ 11¿ù 01ÀÏ 103È£ 13:17~13:30 clincally complete response in patient with MIBC after neoadjuvant chemotherapy: what is next? - bladder preservation strategy ¼ºÇöȯ(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 11¿ù 01ÀÏ 103È£ 13:30~13:45 Optimizing combination therapies or therapeutic sequences for advanced or metastatic UC ÃÖÀ±Áö(°í·ÁÀÇ´ë Á¾¾ç³»°ú)

±³À°½Ã°£ 11¿ù 01ÀÏ 103È£ 13:45~14:00 Clinical usefulness of bladder MRI and VIRADS in bladder cancer. À±¼º±¹(µ¿¾ÆÀÇ´ë ¿µ»óÀÇÇаú)

±³À°½Ã°£ 11¿ù 01ÀÏ 103È£ 14:00~14:15 Nerve sparing female cystectomy  - robotic °­¼®È£(°í·ÁÀÇ´ë)

±³À°½Ã°£ 11¿ù 01ÀÏ 103È£ 14:15~14:30 Nerve sparing female cystectomy  - open À̵¿Çö(ÀÌÈ­ÀÇ´ë)

±³À°½Ã°£ 11¿ù 01ÀÏ 103È£ 14:30~14:45 Neobladder reconstruction in female cystectomy - robotic °­¼®È£(°í·ÁÀÇ´ë)

±³À°½Ã°£ 11¿ù 01ÀÏ 103È£ 14:45~15:00 Neobladder reconstruction in female cystectomy  - open À̵¿Çö(ÀÌÈ­ÀÇ´ë)

±³À°½Ã°£ 11¿ù 01ÀÏ 103È£ 15:00~15:30 Single port robotic partial nephrectomy - Retroperitoneal ±è±¤Çö(ÀÌÈ­ÀÇ´ë)

±³À°½Ã°£ 11¿ù 01ÀÏ 103È£ 15:30~16:00 Single port robotic partial nephrectomy - Transperitoneal °í¿µÈÖ(¿µ³²ÀÇ´ë)

±³À°½Ã°£ 11¿ù 01ÀÏ 103È£ 16:00~16:20 Surgical tips to manage various challenging situations at RARP ¹ÚÁø¼º(À»ÁöÀÇ´ë)

±³À°½Ã°£ 11¿ù 01ÀÏ 103È£ 16:20~16:40 RARP in patient with recurrent prostate cancer after radical prostatectomy ±èų²(ºÎ»êÀÇ´ë)

±³À°½Ã°£ 11¿ù 01ÀÏ 103È£ 16:40~17:00 How to improve oncological outcomes in patients with T3 prostate cancer (wide excision) Á¶°­¼ö(¿¬¼¼ÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦75Â÷ ´ëÇѺñ´¢ÀÇÇÐȸ Á¤±âÇмú´ëȸ (DAY1) : 2023-11-01""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦10Â÷ ¾Æ½Ã¾Æ¡¤¿À¼¼¾Æ´Ï¾Æ »ý¸®ÇÐȸ Çмú´ëȸ (FAOPS 2023) (1ÀÏÂ÷) : 2023-11-01
´ÙÀ½±Û Á¤½Å°Ç°­ÀÇÇаú ÀÓ»óÇöÀåÀÇ ´Ù¾çÇÑ ¹®Á¦µéÀÇ ÃÖ½ÅÁö°ß : 2023-11-01
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 75 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 40 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 48 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 55 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 44 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 45 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 21 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 18 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 46 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 22 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 18 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 46 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 31 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 33 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 28 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷